Imatinib
8 NDCs across 3 manufacturers|8 Generic,0 Brand
Imatinib is used to treat blast crisis, dermatofibrosarcoma, gastrointestinal neoplasms, hypereosinophilic syndrome, lymphoid leukemia and myeloid leukemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Imatinib is available as 8 NDCs from 3 manufacturers (8 generic, 0 brand), with NADAC prices from $0.61 to $2.88 per EA — the most expensive product costs about 4.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
3
competing in market
Price Spread
$0.61 – $2.88
per EA
7d Activity
avg -1.0% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing IMATINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
IMATINIB MESYLATE 400 MG TAB | $2.8764 per EA | -0.94% |
IMATINIB MESYLATE 400 MG TAB | $2.8764 per EA | -0.94% |
IMATINIB MESYLATE 400 MG TAB | $2.8764 per EA | -0.94% |
IMATINIB MESYLATE 400 MG TAB | $2.7670 per EA | — |
IMATINIB MESYLATE 100 MG TAB | $0.8838 per EA | — |
IMATINIB MESYLATE 100 MG TAB | $0.6114 per EA | -1.01% |
IMATINIB MESYLATE 100 MG TAB | $0.6114 per EA | -1.01% |
IMATINIB MESYLATE 100 MG TAB | $0.6114 per EA | -1.01% |
Frequently Asked Questions
What is Imatinib used to treat?
Imatinib is used to treat blast crisis, dermatofibrosarcoma, gastrointestinal neoplasms, hypereosinophilic syndrome, lymphoid leukemia and myeloid leukemia, per the National Library of Medicine's MED-RT classification.
How many Imatinib products are on the market?
The Imatinib drug market contains 8 NDCs from 3 manufacturers — 8 generic and 0 brand products.
What is the price range for Imatinib?
NADAC reference prices for Imatinib range from $0.6114 to $2.8764 per EA — the most expensive product costs about 4.7× the cheapest.
Which manufacturers make Imatinib?
3 manufacturers list Imatinib in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (4), Mylan Institutional LLC (2), Mylan Pharmaceuticals Inc. (2).
How has the price of Imatinib changed recently?
Over the past 7 days, 0 Imatinib NDCs rose and 6 fell, with a market-wide average change of -1.0%.